Breaking News of "Vaccine Distribution" Could Send This $.40 Biotech Stock Soaring

"All In" $.35 Stock Secures COVID-19 Vaccine Rollout HUGE Upside Dear Reader, I want to keep this short because the opportunity is moving fast... This $.35 medical stock has recently secured the rights to distribute and sell the COVID-19 vaccines for Pfizer, Johnson & Johnson, Moderna and AstraZeneca. See for yourself here. You will NOT get another chance like this in a long time, overlooking this is a very big mistake on your part. These 3 Stocks Soared On Similar News 1. Novavax stock sky-rocketed 20% same day 2. Ocugen stock sky-rocketed 31% same day 3. Pfizer stock sky-rocketed 31.7% same day Get in while you still can on the ground floor of this medical company here that distributes the COVID-19 vaccine, and diagnostic test kits as well Additionally, several Wall Street analysts have a strong buy & price target predicting huge upside. See this here before the crowd jumps in. This report right here will give you information about the company name, ticker symbol, and the full analyst report. Sincerely,

Editor, TradingCapitalist Investment Research

Stockguru LLC 711 SW 24th Ave Boynton, Beach, FL 33435 This email is being sent from Investing Chatter. If you no longer wish to receive Investing Chatter emails, please click to unsubscribe.

DISCLAIMER: Stocks and options trading have large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the stocks and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell stocks or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed in this report. The past performance of any trading system or methodology is not necessarily indicative of future results. All trades, patterns, charts, systems, etc., discussed in this report are for illustrative purposes only and not to be construed as specific advisory recommendations. Information contained in this correspondence is intended for informational purposes only and was obtained from sources believed to be reliable. Information is in no way guaranteed. No guarantee of any kind is implied or possible where projections of future conditions are attempted.